Ann Surg Treat Res.  2020 Jul;99(1):37-43. 10.4174/astr.2020.99.1.37.

Clinical characteristics and oncologic outcomes in patients with preoperative clinical T3 and T4 colon cancer who were staged as pathologic T3

• Choo JM
• Baek SJ
• Kwak JM
• Kim J
• Kim SH

• KMID: 2503458
• DOI: http://doi.org/10.4174/astr.2020.99.1.37

Abstract

Purpose
Clinically suspected T4 stage colon cancer from a preoperative exam is often diagnosed as T3 stage colon cancer pathologically after surgery, raising concerns about understaging. The aims of this study were to compare the survival of clinical T3 and T4 colon cancer patients who had received a pathologic T3 stage diagnosis postoperatively.
Methods
Patients who were diagnosed with pathologic T3 stage colon cancer postoperatively were reviewed. Patients with clinically suspected T3 or T4 stage cancer on preoperative exam were enrolled in the study. We compared patient demographics and survival of the cT3 and cT4 groups.
Results
Out of the 536 patients with pT3 colon cancer, 503 patients were cT3 (93.8%) and 33 patients were cT4 (6.2%) preoperatively. The most common reason for suspected clinical T4 stage cancer was free perforation (78.8%). There were no statistically significant differences between the 5-year overall survival and the total 5-year disease-free survival (DFS) between the cT3 and cT4 groups; however, local recurrence was significantly higher in the cT4 group (local 5-year DFS: 98.6% vs. 84.0%, P < 0.001). Multivariate analysis showed cT stage was associated with local recurrence, but the association was not statistically significant (P = 0.056).
Conclusion
Preoperative clinically suspected T4 stage colon cancer showed inferior local recurrence despite a postoperative pathologic diagnosis of T3 stage cancer. It is necessary to address the shortcomings of pathologic exams in the matter of the understaging of T4 colon cancer, and to reinforce the treatment for local control in patients with cT4 colon cancer.

Keyword

Colonic neoplasms; Diagnosis; Survival; Tumor Staging

Figure

• 

  Fig. 1 Five-year overall (A), total disease-free (B), systemic disease-free (C), and local disease-free (D) survivals in the cT3 and cT4 groups.

Reference

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon: International Agency for Research on Cancer;2015.

2. National Cancer Center. Annual report of cancer statistics in Korea in 2015. Goyang (Korea): National Cancer Center;2017.

3. Sjovall A, Blomqvist L, Egenvall M, Johansson H, Martling A. Accuracy of preoperative T and N staging in colon cancer--a national population-based study. Colorectal Dis. 2016; 18:73–79. PMID: 26291535.

4. Elmas N, Killi RM, Sever A. Colorectal carcinoma: radiological diagnosis and staging. Eur J Radiol. 2002; 42:206–223. PMID: 12044699.

5. Thoeni RF. Colorectal cancer. Radiologic staging. Radiol Clin North Am. 1997; 35:457–485. PMID: 9087214.

6. Kijima S, Sasaki T, Nagata K, Utano K, Lefor AT, Sugimoto H. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol. 2014; 20:16964–16975. PMID: 25493009.

7. de Haan MC, van Gelder RE, Graser A, Bipat S, Stoker J. Diagnostic value of CTcolonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol. 2011; 21:1747–1763. PMID: 21455818.

8. Pham TT, Liney GP, Wong K, Barton MB. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol. 2017; 90:20151078. PMID: 28055248.

9. Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a metaanalysis. Lancet Oncol. 2006; 7:52–60. PMID: 16389184.

10. Figueiras RG, Goh V, Padhani AR, Naveira AB, Caamano AG, Martin CV. The role of functional imaging in colorectal cancer. AJR Am J Roentgenol. 2010; 195:54–66. PMID: 20566797.

11. Utano K, Endo K, Togashi K, Sasaki J, Kawamura HJ, Horie H, et al. Preoperative T staging of colorectal cancer by CT colonography. Dis Colon Rectum. 2008; 51:875–881. PMID: 18350337.

12. Nerad E, Lahaye MJ, Maas M, Nelemans P, Bakers FC, Beets GL, et al. Diagnostic accuracy of CT for local staging of colon cancer: a systematic review and metaanalysis. AJR Am J Roentgenol. 2016; 207:984–995. PMID: 27490941.

13. Kothari K, Friedman B, Grimaldi GM, Hines JJ. Nontraumatic large bowel perforation: spectrum of etiologies and CT findings. Abdom Radiol (NY). 2017; 42:2597–2608. PMID: 28493071.

14. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer International Publishing;2017.

15. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer (Version 1. 2018, October 19, 2018). Plymouth Meeting (PA): National Comprehensive Cancer Network;2018. Available from: https://www.nccn.org/patients/guidelines/content/PDF/colonpatient.pdf.

16. White VA, Trotter MJ. Intraoperative consultation/final diagnosis correlation: relationship to tissue type and pathologic process. Arch Pathol Lab Med. 2008; 132:29–36. PMID: 18181670.

17. Asano H, Kojima K, Ogino N, Fukano H, Ohara Y, Shinozuka N. Postoperative recurrence and risk factors of colorectal cancer perforation. Int J Colorectal Dis. 2017; 32:419–424. PMID: 27796497.

18. Lee KY, Park JW, Song I, Lee KY, Cho S, Kwon YH, et al. Prognostic significance of sealed-off perforation in colon cancer: a prospective cohort study. World J Surg Oncol. 2018; 16:232. PMID: 30514318.

19. Belt EJ, Stockmann HB, Abis GS, de Boer JM, de Lange-de Klerk ES, van Egmond M, et al. Peri-operative bowel perforation in early stage colon cancer is associated with an adverse oncological outcome. J Gastrointest Surg. 2012; 16:2260–2266. PMID: 23093449.

20. Biondo S, Kreisler E, Millan M, Fraccalvieri D, Golda T, Marti Rague J, et al. Differences in patient postoperative and long-term outcomes between obstruc tive and perforated colonic cancer. Am J Surg. 2008; 195:427–432. PMID: 18361923.

21. Abdelrazeq AS, Scott N, Thorn C, Verbeke CS, Ambrose NS, Botterill ID, et al. The impact of spontaneous tumour perforation on outcome following colon cancer surgery. Colorectal Dis. 2008; 10:775–780. PMID: 18266887.

22. Chen HS, Sheen-Chen SM. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery. 2000; 127:370–376. PMID: 10776426.

23. Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, et al. Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol. 2017; 3:211–219. PMID: 27787550.

24. Boeckx N, Koukakis R, Op de, Rolfo C, Van Camp G, Siena S, et al. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies. Ann Oncol. 2017; 28:1862–1868. PMID: 28449055.

25. Kim SR, Song N, Yothers G, Gavin PG, Allegra CJ, Paik S, et al. Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology). Br J Cancer. 2018; 118:629–633. PMID: 29241223.